丹塞:一种潜在的干预措施,可以改善中风患者的临床结果
Jian Xu1, Mengfei Zhang1, Leyu Tao1
1Department of Pharmacy, Shaoxing People's Hospital, Shaoxing, China.
Frontiers in pharmacology
|September 25, 2025
概括
在重症监护病房 (ICU) 入院的第一天给予Ondansetron可显著降低中风患者的30天和60天死亡率. 这一发现表明,丹塞可能会改善中风幸存者的整体预后.
科学领域:
- 神经学 神经学
- 临床药理学 临床药理学
- 公共卫生 公共卫生
背景情况:
- 在全球范围内,中风是导致死亡和残疾的主要原因.
- 5HT3受体对手Ondansetron是一种抗emetic药,可能对神经递质失衡产生影响.
- 它对中风患者结果的影响需要进一步调查.
研究的目的:
- 通过使用真实世界的数据,评估丹塞对中风患者临床结果的影响.
- 评估早期安丹塞特朗给药对入住ICU的中风患者死亡率的影响.
主要方法:
- 成年中风患者的回顾性队列分析.
- 倾向性得分匹配 (PSM) 以平衡丹和非丹组之间的基线特征.
- 多变量考克斯回归和卡普兰-梅尔生存分析以评估死亡率.
主要成果:
- 总共有5,297名中风患者被分析;3,926人在ICU入院时接受了丹塞.
- 在PSM之后,2628名患者被对对进行分析.
- 早期使用丹塞显著降低了30天 (HR 0.73,P < 0.05) 和60天 (HR 0.73,P < 0.05) 的死亡率.
结论:
- 丹塞治疗与中风患者的预后改善有关.
- 在ICU入院的第一天给药导致死亡率明显降低.
- 这些发现支持丹塞在中风管理方案中的临床重要性.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
602
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
602
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Coronary Artery Disease IV: Preventive Measures
590
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Regulation of Stroke Volume
4.7K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.7K
Parkinson's Disease: Treatment
986
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
986


